Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1871Triple Negative Breast Neoplasms 126Neoplasms 74Ovarian Neoplasms 56Neoplasm Metastasis 55Colorectal Neoplasms 54Prostatic Neoplasms 53Lung Neoplasms 51Stomach Neoplasms 45Pancreatic Neoplasms 43Motor Activity 41Colonic Neoplasms 41Lymphedema 35Breast Cancer Female 32Advanced Breast Cancer 32Carcinoma, Non-Small-Cell Lung 31Endometrial Neoplasms 28Melanoma 27Breast Diseases 26Head and Neck Neoplasms 25Cardiotoxicity 25HER2-positive Breast Cancer 22Uterine Cervical Neoplasms 21Brain Neoplasms 21Breast Cancer Lymphedema 20Pain 19Fatigue 19Esophageal Neoplasms 19Breast Neoplasms, Male 19Urinary Bladder Neoplasms 18

Interventions

Zoledronic Acid 1Ibandronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Humoral Hypercalcemia Of Malignancy × Breast × Clear all
NCT00326820 2013-03-13

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Wales Cancer Trials Unit

Phase 3 Unknown
1,404 enrolled
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡